Narus Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$234K Hold
666
0.06% 147
2025
Q4
$218K Buy
+666
New +$211K 0.06% 154
2025
Q2
Sell
-716
Closed -$223K 158
2025
Q1
$223K Buy
+716
New +$211K 0.08% 138
2024
Q4
Sell
-716
Closed -$231K 147
2024
Q3
$231K Hold
716
0.08% 138
2024
Q2
$224K Hold
716
0.09% 130
2024
Q1
$204K Hold
716
0.09% 138
2023
Q4
$206K Sell
716
-60
-8% -$16.3K 0.1% 132
2023
Q3
$209K Buy
+776
New +$194K 0.11% 122
2023
Q1
Sell
-793
Closed -$208K 112
2022
Q4
$208K Buy
+793
New +$213K 0.12% 112
2021
Q1
$214K Buy
+860
New +$205K 0.13% 102
2019
Q4
$207K Buy
+860
New +$190K 0.15% 77

Other funds holding AMGN

Narus Financial Partners's AMGN Position: Q1 2026 in Review

Narus Financial Partners held its Amgen (AMGN) position steady in Q1 2026 at 666 shares worth $234K. The position accounts for 0.06% of the portfolio, ranked #147.

Narus Financial Partners first reported a position in AMGN in Q4 2019 and has held it in 11 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Narus Financial Partners held 666 shares of Amgen worth $234K as of Q1 2026.
  • Narus Financial Partners left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.06% of Narus Financial Partners's portfolio in Q1 2026, its #147 holding.
  • Narus Financial Partners first reported a position in Amgen in Q4 2019 and has held it in 11 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Narus Financial Partners's 13F filing for Q1 2026, filed 21 Apr 2026.